NDC properties for "Amjevita 40 MG per 0.4 ML Prefilled Syringe" (RxCUI 2663907)
About this data
The tables show NDC propoerties for Amjevita 40 MG per 0.4 ML Prefilled Syringe with the RxCUI 2663907
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product
Details for Amjevita 40 MG per 0.4 ML Prefilled Syringe (RxCUI 2663907)
| BLA | BLA761024 |
|---|---|
| MMSL_CODE | BD39992 |
| RxCUI | 2663907 |
| SPL_SET_ID | 9c44bd5b-4464-40a4-8933-8680950f00f2 |
| SPL_SET_ID | b7178e36-6787-45ab-8fee-be59bc6a4aa4 |
| SPL_SET_ID | d7862491-2634-4402-b001-dcc1abf8dd58 |
| Prescribable Synonym | AMJEVITA 40 MG in 0.4 ML Prefilled Syringe |
| RXNAV_STR | Amjevita 40 MG per 0.4 ML Prefilled Syringe |
| RxNorm Name | 0.4 ML adalimumab-atto 100 MG/ML Prefilled Syringe [Amjevita] |
| RxNorm Synonym | Amjevita 40 MG per 0.4 ML Prefilled Syringe |
| Related queries | Interactions (for RxCUI 2663907) |
NDC Properties
NDC Item 55513047901
| NDC 9 | 55513-479 |
|---|---|
| NDC 10 | 55513-479-01 |
| NDC Item | 55513047901 |
| Packaging | 1 SYRINGE in 1 CARTON (55513-479-01) / .4 mL in 1 SYRINGE |
| BLA | BLA761024 |
| FDA SPL set id | 807577 |
| Labeler | Amgen Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2023-08-14 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 55513-479 |
NDC Item 55513047902
| NDC 9 | 55513-479 |
|---|---|
| NDC 10 | 55513-479-02 |
| NDC Item | 55513047902 |
| Packaging | 2 SYRINGE in 1 CARTON (55513-479-02) / .4 mL in 1 SYRINGE |
| BLA | BLA761024 |
| FDA SPL set id | 807577 |
| Labeler | Amgen Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2023-08-14 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 55513-479 |
NDC Item 72511047901
| NDC 9 | 72511-479 |
|---|---|
| NDC 10 | 72511-479-01 |
| NDC Item | 72511047901 |
| BLA | BLA761024 |
| FDA SPL set id | 828840 |
| Labeler | Amgen USA Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2024-11-08 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72511-479 |
NDC Item 72511047902
| NDC 9 | 72511-479 |
|---|---|
| NDC 10 | 72511-479-02 |
| NDC Item | 72511047902 |
| Packaging | 2 SYRINGE in 1 CARTON (72511-479-02) / .4 mL in 1 SYRINGE |
| BLA | BLA761024 |
| FDA SPL set id | 828840 |
| Labeler | Amgen USA Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2024-11-08 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72511-479 |
NDC Item 84612047901
| NDC 9 | 84612-479 |
|---|---|
| NDC 10 | 84612-479-01 |
| NDC Item | 84612047901 |
| Packaging | 1 SYRINGE in 1 CARTON (84612-479-01) / .4 mL in 1 SYRINGE |
| BLA | BLA761024 |
| FDA SPL set id | 858781 |
| Labeler | Optum Health Solutions (Ireland) Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2025-01-01 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 84612-479 |
NDC Item 84612047902
| NDC 9 | 84612-479 |
|---|---|
| NDC 10 | 84612-479-02 |
| NDC Item | 84612047902 |
| Packaging | 2 SYRINGE in 1 CARTON (84612-479-02) / .4 mL in 1 SYRINGE |
| BLA | BLA761024 |
| FDA SPL set id | 858781 |
| Labeler | Optum Health Solutions (Ireland) Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2025-01-01 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 84612-479 |
NDC Item 55513047901
| NDC 9 | 55513-479 |
|---|---|
| NDC 10 | 55513-479-01 |
| NDC Item | 55513047901 |
| Packaging | 1 SYRINGE in 1 CARTON (55513-479-01) / .4 mL in 1 SYRINGE |
| BLA | BLA761024 |
| FDA SPL set id | 807577 |
| Labeler | Amgen Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2023-08-14 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 55513-479 |
NDC Item 55513047902
| NDC 9 | 55513-479 |
|---|---|
| NDC 10 | 55513-479-02 |
| NDC Item | 55513047902 |
| Packaging | 2 SYRINGE in 1 CARTON (55513-479-02) / .4 mL in 1 SYRINGE |
| BLA | BLA761024 |
| FDA SPL set id | 807577 |
| Labeler | Amgen Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2023-08-14 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 55513-479 |
NDC Item 72511047901
| NDC 9 | 72511-479 |
|---|---|
| NDC 10 | 72511-479-01 |
| NDC Item | 72511047901 |
| BLA | BLA761024 |
| FDA SPL set id | 828840 |
| Labeler | Amgen USA Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2024-11-08 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72511-479 |
NDC Item 72511047902
| NDC 9 | 72511-479 |
|---|---|
| NDC 10 | 72511-479-02 |
| NDC Item | 72511047902 |
| Packaging | 2 SYRINGE in 1 CARTON (72511-479-02) / .4 mL in 1 SYRINGE |
| BLA | BLA761024 |
| FDA SPL set id | 828840 |
| Labeler | Amgen USA Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2024-11-08 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72511-479 |
NDC Item 84612047901
| NDC 9 | 84612-479 |
|---|---|
| NDC 10 | 84612-479-01 |
| NDC Item | 84612047901 |
| Packaging | 1 SYRINGE in 1 CARTON (84612-479-01) / .4 mL in 1 SYRINGE |
| BLA | BLA761024 |
| FDA SPL set id | 858781 |
| Labeler | Optum Health Solutions (Ireland) Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2025-01-01 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 84612-479 |
NDC Item 84612047902
| NDC 9 | 84612-479 |
|---|---|
| NDC 10 | 84612-479-02 |
| NDC Item | 84612047902 |
| Packaging | 2 SYRINGE in 1 CARTON (84612-479-02) / .4 mL in 1 SYRINGE |
| BLA | BLA761024 |
| FDA SPL set id | 858781 |
| Labeler | Optum Health Solutions (Ireland) Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2025-01-01 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 84612-479 |
NDC Item 55513047901
| NDC 9 | 55513-479 |
|---|---|
| NDC 10 | 55513-479-01 |
| NDC Item | 55513047901 |
| Packaging | 1 SYRINGE in 1 CARTON (55513-479-01) / .4 mL in 1 SYRINGE |
| BLA | BLA761024 |
| FDA SPL set id | 807577 |
| Labeler | Amgen Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2023-08-14 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 55513-479 |
NDC Item 55513047902
| NDC 9 | 55513-479 |
|---|---|
| NDC 10 | 55513-479-02 |
| NDC Item | 55513047902 |
| Packaging | 2 SYRINGE in 1 CARTON (55513-479-02) / .4 mL in 1 SYRINGE |
| BLA | BLA761024 |
| FDA SPL set id | 807577 |
| Labeler | Amgen Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2023-08-14 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 55513-479 |
NDC Item 72511047901
| NDC 9 | 72511-479 |
|---|---|
| NDC 10 | 72511-479-01 |
| NDC Item | 72511047901 |
| BLA | BLA761024 |
| FDA SPL set id | 828840 |
| Labeler | Amgen USA Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2024-11-08 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72511-479 |
NDC Item 72511047902
| NDC 9 | 72511-479 |
|---|---|
| NDC 10 | 72511-479-02 |
| NDC Item | 72511047902 |
| Packaging | 2 SYRINGE in 1 CARTON (72511-479-02) / .4 mL in 1 SYRINGE |
| BLA | BLA761024 |
| FDA SPL set id | 828840 |
| Labeler | Amgen USA Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2024-11-08 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72511-479 |
NDC Item 84612047901
| NDC 9 | 84612-479 |
|---|---|
| NDC 10 | 84612-479-01 |
| NDC Item | 84612047901 |
| Packaging | 1 SYRINGE in 1 CARTON (84612-479-01) / .4 mL in 1 SYRINGE |
| BLA | BLA761024 |
| FDA SPL set id | 858781 |
| Labeler | Optum Health Solutions (Ireland) Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2025-01-01 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 84612-479 |
NDC Item 84612047902
| NDC 9 | 84612-479 |
|---|---|
| NDC 10 | 84612-479-02 |
| NDC Item | 84612047902 |
| Packaging | 2 SYRINGE in 1 CARTON (84612-479-02) / .4 mL in 1 SYRINGE |
| BLA | BLA761024 |
| FDA SPL set id | 858781 |
| Labeler | Optum Health Solutions (Ireland) Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2025-01-01 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 84612-479 |
NDC Item 55513047901
| NDC 9 | 55513-479 |
|---|---|
| NDC 10 | 55513-479-01 |
| NDC Item | 55513047901 |
| Packaging | 1 SYRINGE in 1 CARTON (55513-479-01) / .4 mL in 1 SYRINGE |
| BLA | BLA761024 |
| FDA SPL set id | 807577 |
| Labeler | Amgen Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2023-08-14 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 55513-479 |
NDC Item 55513047902
| NDC 9 | 55513-479 |
|---|---|
| NDC 10 | 55513-479-02 |
| NDC Item | 55513047902 |
| Packaging | 2 SYRINGE in 1 CARTON (55513-479-02) / .4 mL in 1 SYRINGE |
| BLA | BLA761024 |
| FDA SPL set id | 807577 |
| Labeler | Amgen Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2023-08-14 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 55513-479 |
NDC Item 72511047901
| NDC 9 | 72511-479 |
|---|---|
| NDC 10 | 72511-479-01 |
| NDC Item | 72511047901 |
| BLA | BLA761024 |
| FDA SPL set id | 828840 |
| Labeler | Amgen USA Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2024-11-08 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72511-479 |
NDC Item 72511047902
| NDC 9 | 72511-479 |
|---|---|
| NDC 10 | 72511-479-02 |
| NDC Item | 72511047902 |
| Packaging | 2 SYRINGE in 1 CARTON (72511-479-02) / .4 mL in 1 SYRINGE |
| BLA | BLA761024 |
| FDA SPL set id | 828840 |
| Labeler | Amgen USA Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2024-11-08 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72511-479 |
NDC Item 84612047901
| NDC 9 | 84612-479 |
|---|---|
| NDC 10 | 84612-479-01 |
| NDC Item | 84612047901 |
| Packaging | 1 SYRINGE in 1 CARTON (84612-479-01) / .4 mL in 1 SYRINGE |
| BLA | BLA761024 |
| FDA SPL set id | 858781 |
| Labeler | Optum Health Solutions (Ireland) Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2025-01-01 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 84612-479 |
NDC Item 84612047902
| NDC 9 | 84612-479 |
|---|---|
| NDC 10 | 84612-479-02 |
| NDC Item | 84612047902 |
| Packaging | 2 SYRINGE in 1 CARTON (84612-479-02) / .4 mL in 1 SYRINGE |
| BLA | BLA761024 |
| FDA SPL set id | 858781 |
| Labeler | Optum Health Solutions (Ireland) Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2025-01-01 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 84612-479 |
NDC Item 55513047901
| NDC 9 | 55513-479 |
|---|---|
| NDC 10 | 55513-479-01 |
| NDC Item | 55513047901 |
| Packaging | 1 SYRINGE in 1 CARTON (55513-479-01) / .4 mL in 1 SYRINGE |
| BLA | BLA761024 |
| FDA SPL set id | 807577 |
| Labeler | Amgen Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2023-08-14 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 55513-479 |
NDC Item 55513047902
| NDC 9 | 55513-479 |
|---|---|
| NDC 10 | 55513-479-02 |
| NDC Item | 55513047902 |
| Packaging | 2 SYRINGE in 1 CARTON (55513-479-02) / .4 mL in 1 SYRINGE |
| BLA | BLA761024 |
| FDA SPL set id | 807577 |
| Labeler | Amgen Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2023-08-14 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 55513-479 |
NDC Item 72511047901
| NDC 9 | 72511-479 |
|---|---|
| NDC 10 | 72511-479-01 |
| NDC Item | 72511047901 |
| BLA | BLA761024 |
| FDA SPL set id | 828840 |
| Labeler | Amgen USA Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2024-11-08 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72511-479 |
NDC Item 72511047902
| NDC 9 | 72511-479 |
|---|---|
| NDC 10 | 72511-479-02 |
| NDC Item | 72511047902 |
| Packaging | 2 SYRINGE in 1 CARTON (72511-479-02) / .4 mL in 1 SYRINGE |
| BLA | BLA761024 |
| FDA SPL set id | 828840 |
| Labeler | Amgen USA Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2024-11-08 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72511-479 |
NDC Item 84612047901
| NDC 9 | 84612-479 |
|---|---|
| NDC 10 | 84612-479-01 |
| NDC Item | 84612047901 |
| Packaging | 1 SYRINGE in 1 CARTON (84612-479-01) / .4 mL in 1 SYRINGE |
| BLA | BLA761024 |
| FDA SPL set id | 858781 |
| Labeler | Optum Health Solutions (Ireland) Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2025-01-01 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 84612-479 |
NDC Item 84612047902
| NDC 9 | 84612-479 |
|---|---|
| NDC 10 | 84612-479-02 |
| NDC Item | 84612047902 |
| Packaging | 2 SYRINGE in 1 CARTON (84612-479-02) / .4 mL in 1 SYRINGE |
| BLA | BLA761024 |
| FDA SPL set id | 858781 |
| Labeler | Optum Health Solutions (Ireland) Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2025-01-01 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 84612-479 |
NDC Item 55513047901
| NDC 9 | 55513-479 |
|---|---|
| NDC 10 | 55513-479-01 |
| NDC Item | 55513047901 |
| Packaging | 1 SYRINGE in 1 CARTON (55513-479-01) / .4 mL in 1 SYRINGE |
| BLA | BLA761024 |
| FDA SPL set id | 807577 |
| Labeler | Amgen Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2023-08-14 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 55513-479 |
NDC Item 55513047902
| NDC 9 | 55513-479 |
|---|---|
| NDC 10 | 55513-479-02 |
| NDC Item | 55513047902 |
| Packaging | 2 SYRINGE in 1 CARTON (55513-479-02) / .4 mL in 1 SYRINGE |
| BLA | BLA761024 |
| FDA SPL set id | 807577 |
| Labeler | Amgen Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2023-08-14 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 55513-479 |
NDC Item 72511047901
| NDC 9 | 72511-479 |
|---|---|
| NDC 10 | 72511-479-01 |
| NDC Item | 72511047901 |
| BLA | BLA761024 |
| FDA SPL set id | 828840 |
| Labeler | Amgen USA Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2024-11-08 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72511-479 |
NDC Item 72511047902
| NDC 9 | 72511-479 |
|---|---|
| NDC 10 | 72511-479-02 |
| NDC Item | 72511047902 |
| Packaging | 2 SYRINGE in 1 CARTON (72511-479-02) / .4 mL in 1 SYRINGE |
| BLA | BLA761024 |
| FDA SPL set id | 828840 |
| Labeler | Amgen USA Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2024-11-08 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72511-479 |
NDC Item 84612047901
| NDC 9 | 84612-479 |
|---|---|
| NDC 10 | 84612-479-01 |
| NDC Item | 84612047901 |
| Packaging | 1 SYRINGE in 1 CARTON (84612-479-01) / .4 mL in 1 SYRINGE |
| BLA | BLA761024 |
| FDA SPL set id | 858781 |
| Labeler | Optum Health Solutions (Ireland) Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2025-01-01 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 84612-479 |
NDC Item 84612047902
| NDC 9 | 84612-479 |
|---|---|
| NDC 10 | 84612-479-02 |
| NDC Item | 84612047902 |
| Packaging | 2 SYRINGE in 1 CARTON (84612-479-02) / .4 mL in 1 SYRINGE |
| BLA | BLA761024 |
| FDA SPL set id | 858781 |
| Labeler | Optum Health Solutions (Ireland) Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2025-01-01 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 84612-479 |